These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
663 related articles for article (PubMed ID: 34061395)
1. Relative expression of proinflammatory molecules in COVID-19 patients who manifested disease severities. Nigar S; Shah ST; Setu MAA; Dip SD; Ibnat H; Islam MT; Akter S; Jahid IK; Hossain MA J Med Virol; 2021 Oct; 93(10):5805-5815. PubMed ID: 34061395 [TBL] [Abstract][Full Text] [Related]
2. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study. Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952 [TBL] [Abstract][Full Text] [Related]
3. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality. Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W Front Immunol; 2021; 12():668725. PubMed ID: 34276659 [TBL] [Abstract][Full Text] [Related]
4. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China. Chi Y; Ge Y; Wu B; Zhang W; Wu T; Wen T; Liu J; Guo X; Huang C; Jiao Y; Zhu F; Zhu B; Cui L J Infect Dis; 2020 Aug; 222(5):746-754. PubMed ID: 32563194 [TBL] [Abstract][Full Text] [Related]
5. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab. Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616 [TBL] [Abstract][Full Text] [Related]
6. The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Suarez EC; Krishnan RR; Lewis JG Psychosom Med; 2003; 65(3):362-8. PubMed ID: 12764208 [TBL] [Abstract][Full Text] [Related]
7. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome. Hue S; Beldi-Ferchiou A; Bendib I; Surenaud M; Fourati S; Frapard T; Rivoal S; Razazi K; Carteaux G; Delfau-Larue MH; Mekontso-Dessap A; Audureau E; de Prost N Am J Respir Crit Care Med; 2020 Dec; 202(11):1509-1519. PubMed ID: 32866033 [No Abstract] [Full Text] [Related]
8. Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2. Su CM; Wang L; Yoo D Sci Rep; 2021 Jun; 11(1):13464. PubMed ID: 34188167 [TBL] [Abstract][Full Text] [Related]
9. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China. Jin CZ; Zhao Y; Zhang FJ; Yao HP; Wu LJ; Zhao HX; Wei HS; Wu NP Chin Med J (Engl); 2009 Mar; 122(5):530-5. PubMed ID: 19323903 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19. Ling L; Chen Z; Lui G; Wong CK; Wong WT; Ng RWY; Tso EYK; Fung KSC; Chan V; Yeung ACM; Hui DSC; Chan PKS Front Immunol; 2021; 12():763292. PubMed ID: 34938289 [TBL] [Abstract][Full Text] [Related]
11. The Effects of Convalescent Plasma Transfusion on Serum Levels of Macrophage-Associated Inflammatory Biomarkers in Patients with Severe COVID-19. Shohan M; Mahmoudian-Sani MR; Saeedi-Boroujeni A; Iranparast S; Nashibi R; Abolnezhadian F; Yousefi F; Alavi SM; Cheraghian B; Khodadadi A J Interferon Cytokine Res; 2024 Jul; 44(7):316-324. PubMed ID: 38738802 [TBL] [Abstract][Full Text] [Related]
14. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19. Zaid Y; Doré É; Dubuc I; Archambault AS; Flamand O; Laviolette M; Flamand N; Boilard É; Flamand L J Allergy Clin Immunol; 2021 Aug; 148(2):368-380.e3. PubMed ID: 34111453 [TBL] [Abstract][Full Text] [Related]
15. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection. Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S mBio; 2021 May; 12(3):. PubMed ID: 33947753 [TBL] [Abstract][Full Text] [Related]
16. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada. Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740 [TBL] [Abstract][Full Text] [Related]
17. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity. Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514 [TBL] [Abstract][Full Text] [Related]
18. Mild Cytokine Elevation, Moderate CD4 Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972 [TBL] [Abstract][Full Text] [Related]